Introduction
============

To date, there are no standards to assess intra-operative nociception in a quantitative manner. The PMD100™ (Medasense Biometrics Ltd., Ramat Gan, Israel) is a non-invasive nociception monitor. The device integrates multiple physiological, parameters, including heart rate (HR), heart rate variability, photo-plethysmogram wave amplitude, skin conductance level, and number of skin conductance fluctuations, movements and their time derivatives to compute a real-time nociception index, called NOL. All data is measured by a single finger-mounted probe. A monitor displays the nociception level (NOL) expressed as an index. The data is computed every five seconds. The index ranges from 0--100: a NOL of 0 suggests a very low sympathetic activation equal to a nociception free state, while a NOL of 100 suggests high sympathetic activation, representing high nociception levels.

The exact details of the utilized technology can be found elsewhere ^[@ref-1]^.

Recent clinical trials reported that the NOL index might have a higher sensitivity and specificity than heart rate (HR) and mean blood pressure (MBP) to detect painful stimulations such as intubation, incision and tetanic stimulations in patients under general anesthesia ^[@ref-2],\ [@ref-3]^.

Thoracic epidural catheters and neuraxial administered local anesthetics provide excellent intra- and post-operative analgesia ^[@ref-4]^ and are frequently used in patients receiving thoracic surgery to improve post-operative pain and pulmonary recovery ^[@ref-3]^. However, epidural side effects include a dermatomal reduction of sympathetic tone and could therefore affect NOL measurements, which are based on autonomous nervous system variables.

The purpose of this pilot study was to evaluate changes in NOL values after incision for trocar insertion for video-assisted thoracoscopic surgery (VATS) in patients with and without epidural analgesia. This would suggest that the NOL index is a reliable parameter to assess the epidural analgesia in the anesthetized.

Secondary aims included changes in delta NOL index, in HR and delta HR values before and after two clinical stimuli, intubation and skin incision.

Methods
=======

Subjects
--------

After institutional review board approval (\#44750-B) informed consent was obtained from 20 eligible women and men, 18 years of age or older and of American Society of Anesthesiology Physical Status I-III, scheduled for video-assisted thoracoscopic surgery (VATS) at the University of Washington Medical Center in Seattle, USA. The trial was registered with ClinicalTrials.gov on the 11/07/2013 record ID: [NCT01978379](https://clinicaltrials.gov/ct2/show/NCT01978379), the study period was from January till December 2014.

Non-inclusion criteria included refusal, non-English speaking, chronic use of opioid analgesics, severe psychiatric disorder, history of previous thoracotomy, Body Mass Index (BMI)\>40, and current beta-adrenergic blocking agent treatment. Inability to measure the NOL or HR led to exclusion from the data analysis.

Anesthesia, monitoring & NOL Sampling
-------------------------------------

Patients in the *epidural group* (n = 10) received a mid-thoracic epidural catheter at either T7/8 or T6/7 dermatomal level, per surgical request. All other patients (n = 10) were considered as the *no epidural group*, again per surgical request. Randomization, due to surgical preference for epidural analgesia, was not possible.

After successful epidural placement, at least 2 hours before surgery, all catheters were tested with 3ml 1.5% lidocaine (45mg) with 15µg epinephrine added, to confirm epidural catheter tip location.

All patients received 1--2 mg intravenous (i.v.) midazolam for anxiolysis before being transferred to the operating room where standard anesthesia monitoring was applied, including a five-lead electrocardiography, non-invasive arterial blood pressure, continuous pulse oximetry, and a bispectral index monitor (BIS) (Medtronic, Mansfield, MA, USA. Philips Bispectral Index (BIS ^®^), BISx Power Link™, IntelliVue MP70, Philips, Netherland).

Additionally, the PMD100™ nociception monitor finger probe was connected to the middle finger on the blood pressure cuff free arm. NOL values were displayed following a 30 second calibration phase. The NOL data was recorded on a laptop using the Medasense biometric software. For each case, laptop times were adjusted to the time of the Anesthesia Information Management System (DocuSafe Version 7.2, Merge Healthcare, Chicago, IL, USA).

General anesthesia was standardized and induced with intravenous 1.5mg/kg lidocaine, 2 mcg/kg fentanyl, 1--2 mg/kg propofol, and 0.5mg/kg rocuronium. The time between i.v. administration of fentanyl and intubation was standardized for all patients and set at 5 minutes. Intubation was performed with a double lumen 37 or 39 Fr tube. Hypnotic depth was maintained with 1--1.5% end-expiratory sevoflurane concentration and was adapted to the age adjusted minimum alveolar concentration (MAC) at 1 to 1.2 to achieve target BIS values between 40--60. 100% inspired oxygen was used throughout the study period. Positive pressure ventilation mode was used in all patients. Hypotension, defined as a 20% decrease in systolic or diastolic blood pressure from the first measured values in the operating room or a mean arterial pressure below 65 mmHg, was treated with 100 µg phenylephrine bolus as needed. Then patients were repositioned laterally to facilitate the surgical approach to the lung cavity.

Ten minutes before skin-incision patients in the *epidural group* received an epidural bolus of 5ml 2% lidocaine (100mg), while patients in the *no epidural group* were administered an additional 1 mcg/kg fentanyl bolus, five minutes before incision. The study period ended five minutes after skin incision.

Statistical analysis
--------------------

NOL and HR were recorded every five seconds during the study period. Presented values span 90 seconds before and 190 seconds after intubation and incision, respectively.

For *"Pre-stimulation" NOL and HR values*, the values at "-10 seconds" before an event were used, after an Anova one-way analysis showed that pre-stimulation NOL and HR values were stable and did not vary during the preceding 90 seconds period (see [Figure 1](#f1){ref-type="fig"} and [Figure 2](#f2){ref-type="fig"}).

![Variation of nociception level index (NOL) and heart rate (HR) after intubation.\
**A**) NOL variations after tracheal double-lumen intubation. There was no variation over time for the baseline NOL values prior to intubation (One Way ANOVA repeated measures, p=0.2312, F=1.523). There was a statistical significant variation in NOL absolute values after the tracheal intubation (One Way ANOVA repeated measures, p=0.0031, F=4,982). Dunnett's multiple comparisons was used to compare each value to the **control** value at T minus 10sec. **B**) Delta NOL Baseline: There was no variation over time for the baseline delta NOL values prior to intubation (One Way ANOVA repeated measures: p=0.2312, F=1.523). There was a statistical significant variation in NOL absolute values after the tracheal intubation (One Way ANOVA repeated measures: p=0.0031, F=4.982). Dunnett's multiple comparisons was used to compare each value to the **control** value at T minus 10sec. **C**) Heart Rate: Baseline without variation (One Way ANOVA repeated measures: p=0.5807, F=0.5187). After Intubation: significant variation in HR (One Way ANOVA repeated measures: p=0.0056, F=4,846). Dunnett's multiple comparisons was used to compare each value to the **control** value at T minus 10sec. **D**) Delta Heart Rate: Baseline without variation (One Way ANOVA repeated measures: p=0.5807, F=0.5187). After Intubation: significant variation in delta HR (One Way ANOVA repeated measures: p=0.0056, F=4.846). Dunnett's multiple comparisons was used to compare each value to the **control** value at T minus 10sec. For A, B, C and D significant differences with baseline values of each parameter are shown by: \#: p\<0.005, \#\#: p\<0.001, \#\#\#: p\<0.0001.](f1000research-7-16645-g0000){#f1}

![Variation of nociception level index (NOL) and heart rate (HR) after incision.\
**A**) NOL variations after incision. The baseline values (before incision) were analyzed using One Way ANOVA and showed no intra-group time effect (p=0.8148), meaning the NOL baseline values for each group were stable. Baseline NOL values were significantly different between groups before incision (p=0.0354, \*). After incision: One Way ANOVA for repeated measures showed no significant difference in NOL values after incision in the *epidural* group. In the *no-epidural* group, one way Anova analysis and Dunnett's multiple comparisons showed a significant increase of NOL values after incision (\#, \#\#). Two Ways Anova (Time x Epidural) showed an Interaction (p=0.0015) and Bonferroni's multiple comparisons showed a significant difference between *epidural* versus *no- epidural* at 10sec, 30sec and 50sec after incision (p\<0.05). **B**) Delta NOL baseline values showed no difference between groups and were stable Two Ways Anova (Time x Epidural): Interaction p=0.1048, Epidural p=0.5891, Time p=0.4010). After incision, delta NOL increased significantly in the *no-epidural* group (Dunnett's multiple comparison, p\<0.05; \#, \#\#) but not in the *epidural* group. Bonferroni's multiple comparison between *epidural* versus *no-epidural* showed no statistical significant difference. **C** and **D**) HR or Delta HR baselines were stable prior to incision (One Way Anova, no time effect in each group) and not significantly different between groups. After incision, HR did not significantly change in both groups when compared to baseline values (One Way ANOVA, Dunnett's multiple comparison for time, no time effect in each group). Bonferroni's multiple comparison comparing epidural versus without epidural showed no significant difference between two group after incision for HR and delta HR values. For A, B, C and D significant differences with baseline values of each parameter are shown by: \#: p\<0.005, \#\#: p\<0.001.](f1000research-7-16645-g0001){#f2}

For " *Post-Stimulation*" values NOL or HR were averaged every 20 seconds for 180 seconds after an event. In [Figure 1](#f1){ref-type="fig"} and [Figure 2](#f2){ref-type="fig"}, the dots represent values averaged over 20-second periods. NOL and HR values are presented as means and standard deviations.

Pre and post-stimulation data was compared using Anova two-ways analysis and post-hoc analysis, Dunnet's test was performed to evaluate the changes over time for each parameter, as well as the difference between groups ( [Figure 2](#f2){ref-type="fig"}).

Delta NOL/HR signals were calculated by subtracting the baseline NOL and HR values from the signal. The baseline value was defined as the average NOL or HR value over the last 60 seconds before an event (-60 to 0 sec).

For delta NOL and delta HR, the area under the curve (AUC) was calculated in the time window from the stimulus, at 0 sec, to 180 seconds and compared with the Student t-Test.

A p-value of less than 0.05 was considered significant to reject the null hypothesis, which was that average NOL and HR values before and after the two events as well as their changes in patients with and without thoracic epidurals would not change.

For this pilot study, no power calculation was made to determine the number of subjects to be included. This number of subjects per group was arbitrarily set at 10.

The Statistical analysis was performed using IBM SPSS Statistics for Mac version 24.0 (IBM Corp., USA).

Results
=======

After consent was obtained, 20 subjects were included into this pilot study. Due to a technical fault with the study computer and broken cable, only the data of 16 patients could be analyzed; 8 with and 8 without epidural catheters. Demographic data are presented in [Table 1](#T1){ref-type="table"}.

###### Demographic data.

  -----------------------------------------------
                       Epidural\   No Epidural\
                       Group\      Group\
                       *(n=8)*     *(n=8)*
  -------------------- ----------- --------------
  **Age** (years)      54.6        51.4

  **Height** (cm)      169.9       177.9

  **Weight** (kg)      79.4        101.7

  **BMI** (kg/m ^2^)   27.4        32.1

  **ASA - mode**       3           3

  **ASA - range**      1 -- 3      1 -- 4
  -----------------------------------------------

BMI -- Body mass index, ASA -- American Society of Anesthesiologists physical status score.

During the study periods (see methods), no vasoactive drugs such as phenylephrine were administered. After intubation, the NOL and HR increased significantly in all patients by 11.3 points (CI: 2.7--19.9; p=0.013) and 9.4 bpm (CI: 3.3--15.6; p=0.0105), respectively in all patients compared to the baseline value (average of values over 60 seconds before event). NOL and delta NOL significantly increased after intubation for 90 seconds ( [Figure 1 A, B](#f1){ref-type="fig"}). After intubation, NOL values increased 90% compared to baseline values. HR and delta HR also significantly increased after intubation for 130 seconds ( [Figure 1 C, D](#f1){ref-type="fig"}). HR increased only by 12% after intubation when compared to baseline values.

After skin incision mean NOL values in the *no-epidural* group increased by 13.9 points (CI: 7.4--20.3; p=0.001) compared to 5.4 points (CI: -6.3--17.1; p=0.29) in the epidural group. The mean difference between *no-epidural* and *epidural* groups was 8.4 points (CI: -3.7--20.6; p=0.15). After the incision, NOL and delta NOL values significantly increased until 190 seconds in the *no-epidural* group, in the *epidural* group no significant change was observed ( [Figure 2A, B](#f2){ref-type="fig"}).

The skin incision stimulus did not increase HR and delta HR significantly in both groups and the mean difference in HR increase between groups was only 0.8 (CI: -7.6--9.2; p=0.84) ( [Figure 2C, D](#f2){ref-type="fig"}).

The areas under the curve, calculated for delta NOL and delta HR after the incision, showed a significant lower delta NOL AUC in the *epidural* group than the *no-epidural* group ( [Table 2](#T2){ref-type="table"}). AUC calculated for delta HR after incision did not show any significant difference between the groups.

###### Mean area under the curve (AUC) for delta nociception level index (NOL) index and delta heart rate (HR) after incision stimulus.

  AUC                Delta NOL                               Delta HR
  ------------------ --------------------------------------- ----------
  Epidural           3.22                                    -1.26
  Without Epidural   11.12 ^[\*](#tfn2){ref-type="other"}^   1.84

represents p≤0.05, Student t-Test.

###### 

Click here for additional data file.
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Discussion
==========

This is the first study assessing the feasibility of NOL to evaluate the quality of epidural analgesia during a nociceptive stimulation under general anesthesia.

In this pilot study, the level of nociception (NOL) assessed with the PMD100™ pain monitor as well as HR, significantly increased in all our patients after intubation ( [Figure 1](#f1){ref-type="fig"}) as previously reported by other authors ^[@ref-2],\ [@ref-3]^. This significant increase in NOL, Delta NOL, HR and Delta HR lasted for 1.5 to 2 minutes after the stimulus, despite a moderate amount of i.v. fentanyl dose (1mcg/kg) was administered 5 minutes before intubation. This demonstrates that intubation remains a strong, detectable nociceptive stimulus under general anesthesia with appropriate fentanyl analgesia.

In our study, NOL index increased by 90% after intubation whereas HR increased by only 12% for the same stimulus. This finding aligns with previous reports that the NOL index might have a better sensitivity in detecting noxious stimulus such as an intubation ^[@ref-2],\ [@ref-3]^.

Skin incision followed by the first trocar insertion and endoscope placement for the VATS procedure caused a significant NOL index increase in patients without epidurals, despite the standardized fentanyl administration prior to incision. In patients with a prior to incision activated epidural catheter in place, NOL values did not significantly increase after incision ( [Figure 2A, B](#f2){ref-type="fig"}), while the HR did not significantly vary in both groups after incision ( [Figure 2C, D](#f2){ref-type="fig"}) emphasizing the NOL's higher sensitivity and specificity to detect nociceptive stimuli ^[@ref-2],\ [@ref-3]^. The observed smaller variations of the NOL index or the delta NOL after incision in the epidural group is likely caused by effective epidural analgesia and successful attenuation of the nociceptive autonomous response caused by the skin incision ^[@ref-5]^, hence they might be a good quantitative parameter to assess the quality of analgesia provided by an epidural analgesia.

Mean NOL values before skin incision were different between groups. A previous study found the threshold for nociception to be around a NOL index of 12 while values around 20 were associated with mild pain. The authors suggested a NOL value of 16 to be the threshold for pain detection under general anesthesia ^[@ref-2]^. In our study, patients were subjected to many types of stimuli after the induction of general anesthesia: manual ventilation, intubation, lateral positioning which all together can induce a small amount of pain or discomfort and might explain why the basal threshold of NOL was higher (20.3 +/-18 in the epidural group) compared to values reported in previous studies ^[@ref-2],\ [@ref-3]^ when patients were left at rest under general anesthesia.

This is particularly true in the *epidural* group as they did not receive supplementary doses of fentanyl as opposed to the *no-epidural* group (see methods). Because the epidural catheter was placed 2 hours before surgery and only a small (test) dose was injected, no effect of the epidural could be expected before intubation.

We found no difference in NOL values between the *epidural* and *no-epidural* group before intubation ( [Dataset 1](#DS0){ref-type="other"} ^[@ref-6]^). The lower NOL values of the *no-epidural* group before skin incision are likely caused by an analgesic effect of the intravenous fentanyl bolus (1 mcg/kg), given 5 minutes prior, questioning the predictive value of the monitor. Fentanyl yields a rapid onset of systemic analgesia, whereas epidural analgesia is dermatomal, only.

Monitors of nociception assess single or multiple changes of the autonomous nervous system, including HR and its variability, skin vasomotor reflex and conductance, and photoplethysmogram ^[@ref-7]--\ [@ref-10]^. Some literature suggests that multi parametric indices are more sensitive compared to single parameter devices to detect mild and moderate noxious stimulation ^[@ref-1],\ [@ref-11],\ [@ref-12]^. There is no literature to date evaluating the effect of regional anesthesia on the variation of indexes after painful stimulus offered by these monitors.

In an obstetric population, lumbar epidurals were found to increase HR variability due to an increase in parasympathetic activity after epidural analgesia ^[@ref-13]^. Another study found that a neuraxial blockade reduced low-frequency power and high-frequency power of HR variability, suggesting a total decrease in autonomic activity ^[@ref-14]^.

Epidural autonomous nervous system blockade effects include dermatomal sympathectomy, hypotension, changes in skin temperature regulation ^[@ref-15],\ [@ref-16]^, decrease of cardiac accelerator fibers tone, and a slight reduction in heart rate ^[@ref-17],\ [@ref-18]^. Theoretically, all these changes could affect nociception measurements, such as the NOL.

Mid-thoracic epidural analgesia (T5-T11) inhibits efferent sympathetic preganglionic outflow, causing vasodilatation of the highly compliant splanchnic bed in a dose dependent manner that leads to a decrease of systemic arterial pressure because of venous pooling of blood in this region ^[@ref-13],\ [@ref-19]^. Additionally, the relative hypovolemia, secondary to the epidural sympathectomy-mediated vasodilatation might cause a physiological tachycardic response, potentially increasing NOL values in the epidural group; we did not observe this in our study.

We recognize several limitations in our study: a double blind randomized study design might have been a better choice, but this would have added complexity. This pilot study aimed at whether epidural analgesia can be detected by NOL in patients under general anesthesia in order to design stronger studies. Further, all data were electronically recorded, hence NOL values could not be influenced by the research, anesthesia or surgical teams. We are presenting the results of small pilot and feasibility study, future larger studies are warranted to evaluate if the NOL is useful for titration of epidural local anesthetics during combined general-epidural anesthesia.

In summary, this is the first study looking at the feasibility of assessing the NOL index in patients under general anesthesia and thoracic epidural analgesia and its ability to assess intra-operative epidural analgesia.
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Dataset 1: Nociception level index (NOL) Dataset [10.5256/f1000research.15279.d207164](http://dx.doi.org/10.5256/f1000research.15279.d207164) ^[@ref-6]^

The PMD100™ device and the finger electrodes supplies have been offered by the company Medasense Biometrics Ltd for this study.
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This observational pilot study was designed to evaluate the feasibility of monitoring the autonomic nervous system response to intraoperative stress (intubation and skin incision), by a novel and unique multi-parameter device, the nociception level index (NOL) compared to the heart rate response (HR) under sevoflurane general anesthesia for VATS.

For the skin incision, the authors separated the patients in 2 groups of 8 each: 100 mg lidocaine bolus through an epidural catheter versus 1 mcg/kg intravenous fentanyl. The authors showed that NOL variations were more sensitive than HR variations in detecting the skin incision stress.

This pilot study confirmed the reliability of monitoring by the NOL the autonomic response after the two most common intraoperative stresses (intubation and skin incision).

Despite several limitations that have been well-discussed by the authors (not randomized, high basal NOL values in the epidural group), these encouraging results have to be confirmed by future larger studies and compared to other available nociception monitoring devices (SPI, Analgesia Nociception Index) in various clinical settings.

Future studies should also focus on the clinical impact of monitoring nociception by the NOL in terms of postoperative pain and analgesic consumption.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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The authors have performed a study aiming at assessing NOL response to intubation and incision in patients undergoing video-assisted thoracoscopic surgery with or without epidural analgesia. The study followed a quasiexperimental non-randomized design. In total, 20 patients were included, and 16 were analyzed (8 in each group). They observed that NOL, ∆NOL, HR and ∆HR increased significantly in all patients after intubation. After skin incision, NOL and ∆NOL increased significantly in the epidural group, whereas no difference was observed for HR and ∆HR. The AUCs for ∆NOL and ∆HR after stimulus during 180 s were calculated. A significant difference was observed for ∆NOL AUC in patients with or without epidural analgesia. This was not observed for ∆HR. The authors conclude that NOL may be useful to evaluate the efficacy of an intraoperative thoracic epidural analgesia.

Although of interest, there are some concerns regarding this study.

**Major Concerns:** The authors should emphasize the fact that this study was a non-randomized quasiexperimental study performed on a small amount of patients (8 per group). Although some variations were observed, the results should be considered with caution and confirmed by larger trials.Could the authors explain why ANOVA for repeated measures (and corresponding post hoc tests) were not performed for all time by group interactions ? It is unclear to me why no intergroup analysis was assessed (epidural vs no epidural) during time for intubation.The AUC is somewhat confusing and should be better described (and referenced). What is exactly the information provided by this parameter? Moreover, this study doesn\'t provide any threshold for NOL or ∆NOL variation to assess any outcome. Could the author better explain how these variations may be useful to modify anything in the anesthesia protocol? **Minor Concerns:** Microgram should be labeled µg , not mcg, in the entire manuscript. Please correct.Seconds should be labeled s, not sec, in the entire manuscript and figures. Please correct.Table 2: please provide estimates of dispersion for AUC (95% CI, SD,\...) and present data with groups in columns and values (∆NOL and ∆HR in rows).

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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The authors provide pilot study which try to evaluate the interest to monitor the anesthesia and surgical stresses by the NOL index (multiple physiological parameters). It was a prospective observational study with patients scheduled for video-assisted thoracoscopic surgery with or without thoracic epidural analgesia (function of patient preference). The comparison was made between the NOL and the usual cardiovascular response (HR, and MBP). During the first step the authors compare the variations during and just after the tracheal intubation under regular anesthesia protocol (lidocaine, fentanyl, propofol then sevoflurane, and rocuronium) under BIS monitoring. During the second step; similar evaluation was performed during the surgical incision (epidural 5mL lidocaine 2% Vs. bolus 1mcg/mL fentanyl). The authors reported a more sensitive and reliable NOL variations than HR variations (with or without sympathetic protection; i.e. intubation Vs. thoracic surgical incision).  

My major remark is just based on semantic reflection. Instead of a discussion of intra-operative nociception it could be better to discuss the cardiovascular response to the stress, or in a more general way to the sympathetic / para sympathetic balance assessment to the anesthetic stress (intubation) and surgical stress (skin incision in this study).

Minor Points:

The authors must clarify the procedure used to control the epidural catheter tip location (ephedrine is just for the accidental IV administration) and his true efficacy (postoperative pain evaluation; not only by the lack of supplementary intraoperative doses of fentanyl). Table 1 results must be expressed with variations (i.e. +/- SD). It is a pity that the postoperative pain evaluation was not reported, and correlate or not, with NOL variations (or with the AUC of NOL). 

Despite several limitations in the study reported by the authors (not double-blind randomization); the concept proof of reliable monitoring by the NOL index is confirmed in this pilot study. Unfortunately, the authors did not try to correlate these NOL variations with the level of postoperative pain (or analgesic consumption).

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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**Summary:**

This pilot study evaluated the efficacy of an intraoperative thoracic epidural analgesia by using a multi-parameter device, the nociception level index (NOL).

The authors offer an interesting perspective on the use of a multi-parameter intra-operative nociception device in patients undergoing VATS.

**Comments:**

Abstract:

please mention in the conclusion that more studies are needed.

Introduction:

please mention that NOL is the only nociception monitor currently available combining several parameters (in contrast to for example ANI; SPI)

Discussion:

In the limitations, you state that randomization would have added complexity. Can you please explain this?

Please mention in the conclusion that future large studies are warranted.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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